The Canadian Licensed Producer announced it has completed its first harvest at its wholly-owned subsidiary Tilray Portugal Unipessoal (Tilray Portugal). Sascha Mielcarek, Managing Director, Tilray Europe, said the the first harvest is a ‘key milestone’ for the company as it ‘looks to supply the medical cannabis market in Europe’.
Tilray Portugal is based in the small town of Cantanhede, just over 130 miles north of Lisbon and totals nearly 250,000 square feet of indoor, outdoor and greenhouse cultivation. It also features research labs, processing, packaging and distribution for medical cannabis products.
Known as the Tilray EU Campus it currently employs over 100 people, with that number expected to double by the end of 2019, as more harvests are gathered and production ramped up. The company has also announced a deal to to export a wholesale shipment of $3.3 million worth of medical cannabis from Portugal to Cannamedical in Germany.
Founded in 2016 in Cologne, Cannamedical is licensed to import and distribute high quality medical cannabis products and supplies 2,500 pharmacies and clinical facilities across the country. Cannamedical CEO David Henn said: “Tilray’s product passed our strict quality control standards, and we’re excited to have found a partner able to deliver medical cannabis products for use in Cannamedical’s own brands.
“We look forward to increasing access for patients in need across the country.”
The Portugal facility is a cornerstone international asset for Tilray, which, like many large North American cannabis companies, has global ambitions. It received a license to grow, import, and export bulk medical cannabis in Portugal in mid-2017 and believes that Germany’s legalization of medical marijuana will be replicated throughout the E.U.
Ontario-based Tilray has also announced it has expanded its Portuguese footprint – chosen because of its warm climate – with an agreement to add an additional 20 hectares of outdoor cultivation space in Alentejo. Tilray CEO Brendan Kennedy said its EU campus is an ‘important differentiator, which will enable it to reduce costs and improve margins while hedging against regulatory risk’.
However, the growth of Portugal’s medical cannabis industry has come under fire from the country’s traditional hemp growers who fear they are being forced out of business.
The post Tilray’s ‘E.U. Campus’ Delivers First Harvest And Order appeared first on Cannadelics.
The line is old and never made sense in the first place, but politician after politician like to extol the fear that if they legalize cannabis, everyone will become a pothead. As it turns out, study after study say the opposite, that legalizations don’t increase cannabis use, particularly in younger populations. Take a look. Yet […]
The post Another Study Says Legalizations Don’t Increase Cannabis Use appeared first on Cannadelics.
All eyes are on Switzerland as the country makes big moves to start its own cannabis industry. The country announced plans for a recreational measure last year, and now Switzerland is introducing a wide-reaching medical program that goes far beyond its previous limits. Switzerland is on a rampage, both widening its medical cannabis program, and […]
The post Switzerland Implements Wide-Reaching Medical Cannabis Program appeared first on Cannadelics.
The psychedelics industry is gearing up for a massive debut, and opinions on the compounds are changing for the better. How popular are psychedelics in America right now? New survey results show that these compounds are not unknown to the American public, and that close to 30% of respondents, have already tried them. With the […]
The post How Popular Are Psychedelics In America? Survey Says ~30% Have Tried appeared first on Cannadelics.
